Sysmex (OTCMKTS:SSMXY) Shares Gap Up – Here’s What Happened

Shares of Sysmex Corporation ADR (OTCMKTS:SSMXY) gapped up prior to trading on Tuesday . The stock had previously closed at $9.84, but opened at $10.44. Sysmex shares last traded at $9.9950, with a volume of 1,425 shares.

Wall Street Analysts Forecast Growth

Separately, The Goldman Sachs Group raised shares of Sysmex from a “hold” rating to a “buy” rating in a report on Thursday, October 9th. One research analyst has rated the stock with a Buy rating and one has issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy”.

Sysmex Stock Up 0.2%

The stock has a market capitalization of $6.31 billion, a P/E ratio of 20.04 and a beta of 1.13. The company has a current ratio of 3.34, a quick ratio of 2.49 and a debt-to-equity ratio of 0.11. The firm’s fifty day moving average is $9.92 and its 200-day moving average is $12.65.

Sysmex (OTCMKTS:SSMXY) last posted its quarterly earnings data on Wednesday, November 5th. The company reported $0.16 earnings per share for the quarter, hitting the consensus estimate of $0.16. Sysmex had a net margin of 9.32% and a return on equity of 9.86%. The company had revenue of $826.60 million during the quarter, compared to analyst estimates of $880.80 million. As a group, equities research analysts predict that Sysmex Corporation ADR will post 0.57 earnings per share for the current year.

About Sysmex

Sysmex Corporation (OTCMKTS: SSMXY) is a Japan‐based provider of in vitro diagnostic solutions, specializing in haematology, coagulation, urinalysis and immunochemistry systems. Headquartered in Kobe, the company designs and manufactures a comprehensive portfolio of automated analyzers, reagents and software to support clinical laboratories, hospitals and research institutions. Sysmex’s product lineup also includes digital pathology platforms and data management tools that integrate workflow automation and advanced analytics.

The company’s core offerings center on haematology analyzers such as the XN-Series, which deliver high‐speed, high‐volume testing for blood cell counts and differential analysis.